← Back

Shandong Weigao Orthopaedic Device Co. Ltd. A

Shandong Weigao Orthopaedic Device Co., Ltd. researches, develops, produces, and sells orthopedic medical devices. Its offerings include implantable devices and surgical instruments, such as spinal internal fixation and interbody fusion systems, trauma products like locking plates and intramedullary nails, and joint prostheses for hip, knee, and shoulder. It also provides sports medicine products, craniofacial surgery products, and orthopedic diagnostic equipment. Founded in 2005 and based in Weihai, China, it operates as a subsidiary of Shandong Weigao Group Medical Polymer Co., Limited.

Price · split & dividend adjusted
News & notes moving 688161.CG
688161.CG▼3

Wego Orthopedic's 2026 interim net profit was 132 million yuan, down 6.85% year on year

Wego Orthopedic released its 2026 interim report. Total operating revenue was 704 million yuan, down 4.93% from the same period last year. Net profit attributable to the parent company was 132 million yuan, down 6.85% year on year. Net cash inflow from operating activities was 140 million yuan, down 24.59% year on year. The company's latest asset-liability ratio was 18.74%, gross margin was 63.57%, return on equity was 3.15%, and diluted earnings per share was 0.33 yuan. The number of shareholders was 10,100, and the top ten shareholders held 85.01% of total share capital.
688161.CG ▼
Jiemian·24dRead more →
688161.CG▲

Wego Orthopedics Plans Cash Dividend of 0.9 Yuan per 10 Shares

Wego Orthopedics announced plans to distribute a cash dividend of 0.9 yuan per 10 shares, including tax, to all shareholders, totaling 35.76 million yuan, representing approximately 27.04% of its half-year net profit attributable to the parent company. In the first quarter of 2026, Wego Orthopedics achieved revenue of 296 million yuan and a net profit attributable to the parent company of 44.23 million yuan.
688161.CG ▲
财中社·25dRead more →
© 2026 MarketDXAsset